Metraipolis › archive › dc_54ffb68b7e63
JAK inhibitors and adverse cardiovascular events: Class effect or molecule-specific risk? — Europe PMC PMID:42774336
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42774336
- DOI
- 10.3389/fphar.2026.1896980
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T00:37:55.717Z
- SHA-256 of the archived text
c662c57d3bf0ef936e6a51a594be8411c613810fd0c168993f8a1e185b32e73d- Stable URL of this page
https://metraipolis.com/documento/dc_54ffb68b7e63
How to cite
JAK inhibitors and adverse cardiovascular events: Class effect or molecule-specific risk? — Europe PMC PMID:42774336 — Europe PMC (en), https://europepmc.org/article/MED/42774336 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_54ffb68b7e63 (Metraipolis archive dc_54ffb68b7e63, sha256 c662c57d3bf0ef936e6a51a594be8411c613810fd0c168993f8a1e185b32e73d)
BibTeX
@misc{dc54ffb68b7e63,
title = {JAK inhibitors and adverse cardiovascular events: Class effect or molecule-specific risk? — Europe PMC PMID:42774336},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42774336},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_54ffb68b7e63; sha256 c662c57d3bf0ef936e6a51a594be8411c613810fd0c168993f8a1e185b32e73d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42774336. Agents can read the archived copy with the MCP tool read_document.